Copay Cards: The Cap Is the Product

A manufacturer copay card does not set your price. It sets a maximum contribution, and your price is whatever is left after that contribution runs out. Read from that direction, "pay as little as $25" stops being a headline and becomes a conditional — and the condition is printed in the terms.

The floor, and the number that decides whether you reach it

Lilly's Zepbound savings card, for a patient with commercial insurance that covers the single-dose pen, advertises "as little as $25" per fill. The same terms then state the constraint: "Card savings are subject to a maximum monthly savings of up to $100 per 1-month prescription, $200 per 2-month prescription, or $300 per 3-month prescription fill and a separate maximum annual savings of up to $1,300 per calendar year."¹

Work it through. The card pays up to $100 a month. So $25 is what you pay only if your insured cost is $125 or less. If your plan leaves you at $300, the card takes $100 and you pay $200 — eight times the advertised figure, with the card working exactly as designed.

The annual cap reconciles with the monthly one exactly: $100 × 13 = $1,300. Nothing is being hidden. It is simply that the number in the advert is the best case and the number in the terms is the mechanism.

Novo's version, same shape

NovoCare's footnotes for the Wegovy and Ozempic savings offers say: "Pay as little as $25, subject to a maximum savings of $100/month."² Same floor, same ceiling, same conditional.

Who is excluded, in the manufacturer's own words

Both programmes disqualify government-insured patients by name, and neither is subtle about it.

Lilly's eligibility criteria require that "you are not enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE/CHAMPUS, or any state prescription drug assistance program."¹

Novo's enrolment page asks the question directly and adds the trap most people fall into: "Individuals with both commercial and government-funded plans ARE considered patients with government insurance." It then carves out the exceptions in the other direction — the Federal Employees Health Benefits Program, Affordable Care Act exchange plans, and state employee plans are "NOT federal or state government health care programs for purposes of this savings offer."³

So an exchange plan qualifies you. Being dual-enrolled disqualifies you. Those two sentences sit within a screen of each other and decide eligibility for a large number of people.

What card spending does to your deductible: nothing

This is the part that costs real money and appears in no advertisement.

Novo states it plainly on the savings-offer page: "This offer operates outside of any third-party insurance. The money spent and discounts on your prescription will not count toward your deductible or out-of-pocket requirements and cannot be submitted for reimbursement to your insurer."³

Lilly's self-pay card terms make the patient agree to the same thing — that they will not seek reimbursement from any third-party payer "nor apply those costs toward any deductible or true out-of-pocket requirements."¹

If you are heading toward your plan's out-of-pocket maximum on other care, a copay card is genuinely cheaper this month and quietly more expensive across the year, because it stops the meter. We work that trade through in what "covered" actually promises.

The clause that voids the card entirely

Buried in Lilly's terms is a category most people have never heard of. If your plan participates in an "alternate funding program" that requires you to apply to the savings card programme, or to pursue coverage through an alternate funding vendor, as a condition of coverage, then "you are not eligible for and are prohibited from using" the card.¹

Lilly also reserves the right to reduce or eliminate savings if your plan "does not apply Card payments to satisfy your co-payment, deductible, or coinsurance" — the mechanism usually called a copay accumulator.¹ This is a live fight between manufacturers and plans, and the patient is standing between them.

Fill counts and expiry dates

Cards do not run on your prescription's schedule. They run on their own.

Lilly's card for the single-dose pen "may be used for a maximum of up to 13 prescription fills per calendar year." The KwikPen version of the same card allows "up to 11 prescription fills per calendar year," with a month defined as 28 days.¹ Eleven 28-day fills is 308 days. That is a real ceiling, and it is not twelve months.

Both cards carry the same end date: "Card expires and savings end on 12/31/2026."¹ Every figure in this article is a snapshot read on 7 August 2026 and none of it is promised past that date — Lilly reserves the right to amend the terms "at Lilly's sole discretion, without notice, and for any reason."¹

We take the fill-count arithmetic further in thirteen charges, twelve months.

The four questions to ask before you count on a card

What is the maximum monthly savings, in dollars?

What is the annual maximum, and how many fills does it allow?

Does my insurance type disqualify me — including if I hold both a commercial and a government plan?

Does my plan apply card payments toward my deductible, or not?

Answer those four and you can price the year. The advertised floor answers none of them.